Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    88,020.89
    -771.48 (-0.87%)
     

  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Top Ranked Momentum Stocks to Buy for January 22nd

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 22nd:

Apple Inc. (AAPL): This manufacturer of smartphones has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.

Apple Inc. Price and Consensus

Apple Inc. Price and Consensus
Apple Inc. Price and Consensus

Apple Inc. price-consensus-chart | Apple Inc. Quote

Apple’s shares gained 11.5% over the last one month more than S&P 500’s gain of 3%. The company possesses a Momentum Score of A.

Apple Inc. Price

Apple Inc. Price
Apple Inc. Price

Apple Inc. price | Apple Inc. Quote

Adaptimmune Therapeutics plc (ADAP): This clinical-stage biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.6% over the last 60 days.

Adaptimmune Therapeutics PLC Price and Consensus

Adaptimmune Therapeutics PLC Price and Consensus
Adaptimmune Therapeutics PLC Price and Consensus

Adaptimmune Therapeutics PLC price-consensus-chart | Adaptimmune Therapeutics PLC Quote

ADVERTISEMENT

Adaptimmune Therapeutics’ shares gained more than 100% over the last one month. The company possesses a Momentum Score of A.

Adaptimmune Therapeutics PLC Price

Adaptimmune Therapeutics PLC Price
Adaptimmune Therapeutics PLC Price

Adaptimmune Therapeutics PLC price | Adaptimmune Therapeutics PLC Quote

AssetMark Financial Holdings, Inc. (AMK): This operator of wealth management and technology solutions has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.

AssetMark Financial Holdings, Inc. Price and Consensus

AssetMark Financial Holdings, Inc. Price and Consensus
AssetMark Financial Holdings, Inc. Price and Consensus

AssetMark Financial Holdings, Inc. price-consensus-chart | AssetMark Financial Holdings, Inc. Quote

AssetMark Financial’s shares gained 3.6% over the last one month. The company possesses a Momentum Score of A.

AssetMark Financial Holdings, Inc. Price

AssetMark Financial Holdings, Inc. Price
AssetMark Financial Holdings, Inc. Price

AssetMark Financial Holdings, Inc. price | AssetMark Financial Holdings, Inc. Quote

Cardlytics, Inc. (CDLX): This operator of a purchase intelligence platform has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Cardlytics, Inc. Price and Consensus

Cardlytics, Inc. Price and Consensus
Cardlytics, Inc. Price and Consensus

Cardlytics, Inc. price-consensus-chart | Cardlytics, Inc. Quote

Cardlytics’ shares gained 40.6% over the last one month. The company possesses a Momentum Score of A.

Cardlytics, Inc. Price

Cardlytics, Inc. Price
Cardlytics, Inc. Price

Cardlytics, Inc. price | Cardlytics, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.6% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cardlytics, Inc. (CDLX) : Free Stock Analysis Report
 
AssetMark Financial Holdings, Inc. (AMK) : Free Stock Analysis Report
 
Adaptimmune Therapeutics PLC (ADAP) : Free Stock Analysis Report
 
Apple Inc. (AAPL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research